Defy Medical describes hormone treatment for women and a broad range of formulations, including compounded combinations. Its published materials discuss estradiol, estriol, progesterone, testosterone and other hormones rather than a single standardized menopause product.

That breadth makes a product-level conversation especially important. The useful question is not how many hormones a clinic offers, but which symptom each proposed medicine is meant to address, what evidence supports it and how the plan will be monitored.

What the public materials describe

Defy’s guide to BHRT for women discusses oral, topical, injectable and other delivery options. It also discusses combinations such as estradiol with estriol, sometimes called Bi-Estrogen. Its compounding article describes the use of pharmacies to prepare customized formulations. Those materials establish that compounding is part of the service model; they do not verify the exact plan or price for an individual patient.

A longer hormone list should not be read as a more complete or better treatment by itself. DHEA, pregnenolone, testosterone and estrogen have different uses and evidence. A symptom such as fatigue can have many causes, and adding a hormone is not a substitute for assessing those possibilities. Ask for a clear rationale for each item rather than accepting a package as an indivisible program.

Bioidentical does not settle the regulatory question

Some FDA-approved estradiol and progesterone products are bioidentical. A compounded combination may also contain bioidentical hormones, but the finished medicine has not undergone FDA premarket review for safety, effectiveness and quality. A pharmacy’s licensing or registration is not approval of every product it dispenses.

ACOG recommends against routine use of compounded bioidentical menopause therapy when approved options can meet the patient’s needs. If a clinician proposes compounding, ask what individual need makes it appropriate and which approved alternatives were considered. The compounding guide explains how to ask this without assuming that customization is either automatically necessary or automatically inappropriate.

Separate the consultation, tests and medication bill

We did not establish a single current, all-inclusive menopause HRT price from the reviewed pages. Do not import a testosterone program price or another product’s advertised cost into a menopause comparison. Ask for an itemized estimate covering the initial consultation, required tests, medication, supplies, shipping and ongoing reviews.

Clarify whether outside laboratory results are accepted, whether testing can use your insurance and whether follow-up frequency depends on the medication. If multiple hormones are prescribed, request the cost of each. That makes it easier to understand a change in the total bill and to discuss whether a simpler treatment plan could address the original concern.

More routes mean more practical questions

A cream, capsule, injection and pellet do not behave identically. Ask how the route affects absorption, reversibility, side effects and monitoring. If a long-acting preparation is discussed, understand how difficult it may be to adjust or stop exposure once it has been administered. An online consultation does not mean that every proposed procedure can happen at home.

A compounded estrogen-and-progesterone cream deserves particular attention if you have a uterus. The presence of progesterone on the label does not by itself establish adequate endometrial protection. The prescriber should explain the evidence for the regimen and the plan for evaluating bleeding. Read why progesterone matters before the visit.

Testosterone is a distinct decision

Testosterone should not be treated as a routine addition to every menopause plan. There is no FDA-approved testosterone formulation specifically indicated for women in the United States. Discussion should cover the treatment target, limited evidence outside selected sexual-health indications, the possibility of androgen-related side effects and how excessive exposure will be avoided.

Laboratory monitoring can be part of that discussion, but a laboratory value alone does not diagnose the cause of low desire or low energy. Review relationship factors, medication effects, pain, sleep and other medical issues with a qualified clinician. Our testosterone article offers a more focused set of questions.

How we would use this review

Defy is a provider to investigate when you want a detailed discussion of a broad hormone menu and understand that some options are compounded. Readers primarily seeking a straightforward approved estradiol option may find Alloy or Midi useful comparisons. Those are different service models, not evidence of one brand’s clinical superiority.

We have not enrolled, evaluated the quality of a consultation, audited a dispensing pharmacy or established comparative patient outcomes. Treat the review as preparation for an informed conversation. Obtain the proposed prescription and full cost in writing, then decide whether the complexity of the plan is justified by your actual medical needs.

FOLLOW THE EVIDENCE

Sources & further reading

Provider pages support service and price descriptions. Medical guidance supports treatment explanations. Neither is a first-hand review of patient outcomes. Checked September 20, 2026.

  1. Defy Medical: BHRT for women
  2. Defy Medical: compounding pharmacies
  3. ACOG: compounded bioidentical menopausal hormone therapy, reaffirmed 2026
  4. FDA: understanding the risks of compounded drugs
  5. The Menopause Society: hormone therapy
This is educational information, not a diagnosis or a treatment plan. A licensed clinician should assess your medical history and any proposed prescription. For a medical emergency, call 911.